ConductScience.org, home

Comparison · NCT04149535-fd8e0dfc

TAVR With Sentinel vs TAVR Without Sentinel: The Rate of Stroke Through 72 Hours Post TAVR Procedure or Discharge (Whichever Comes First)

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. TAVR With Sentinel vs TAVR Without Sentinel: The Rate of Stroke Through 72 Hours Post TAVR Procedure or Discharge (Whichever Comes First). Trial comparisons, record NCT04149535-fd8e0dfc. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT04149535-fd8e0dfc

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.02270.01630.0315wilson
Risk in group 20.02870.02140.0384wilson
Risk difference, group 1 minus group 2-0.00603-0.01770.00544newcombe hybrid score
Risk ratio, group 1 over group 20.790.5061.23log
Odds ratio, group 1 over group 20.7850.4981.24log
Number needed to treat, for one fewer participant with the outcome on TAVR With Sentinel than on TAVR Without Sentinel166from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1TAVR With SentinelPatients assigned to this group will undergo TAVR with the Sentinel® Cerebral Protection System.~Sentinel® Cerebral Protection System: cerebral embolic protection system341,501OG000
Group 2TAVR Without SentinelPatients assigned to this group will undergo TAVR without the Sentinel® Cerebral Protection System.431,499OG001

Outcome

Type
PRIMARY
Title
The Rate of Stroke Through 72 Hours Post TAVR Procedure or Discharge (Whichever Comes First)
Description
All stroke (hemorrhagic, ischemic, or undetermined status; disabling or nondisabling) through 72 hours post TAVR procedure or discharge (whichever comes first), as adjudicated by an independent Clinical Events Committee (CEC) and using Neurologic Academic Research Consortium (NeuroARC) definitions.
Time frame
<=72 hours
Population
Intent-to-Treat

Source ClinicalTrials.gov

Trial

Title
PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement
NCT number
NCT04149535
Phases
NA
Conditions
Stroke
Interventions
Sentinel® Cerebral Protection System
Lead sponsor
Boston Scientific Corporation
Results first posted
2023-02-02

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT04149535-fd8e0dfc